CClinicalTrials.gg
Status unknownNCT03302572Updated Oct 5, 2017

Effectiveness Brief Information Advanced Directives Primary Care

An interventional study of Brief information group in Primary Care, Advance Directives and Randomized Controlled Trial, sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina. Status unknown at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-10-05.

Sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Sep 2017), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
330
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The knowledge and completion of advanced directives (ADs) by the population is generally low. Primary care could develop a very important role to inform and assist in the preparation of this document because of its accessibility.

Objective: To evaluate the effectiveness of an oral brief information and a brochure administered in primary care to improve the proportion of ADs records.

Design: Randomized clinical trial. Ambit: 7 offices from a urban health center which serves about 25,000 users older than 18 years.

Material and methods It will be administered randomly triptych and oral brief information about the existence of advance directives for people over 18 to attend the appointment of their family doctor for any reason (intervention group). It will be given the possibility of more extensive information if they wish and collaboration will be offered for the advance directive according to patient preferences. The control group will not receive any information. Follow-up: 3 months. Variables will be: number of people interested in ADs, number of ADs made and demographic data (gender, age, education level, race, comorbidities, religion, testament) in both groups. Statistical analysis: multiple linear regression, Poisson and Cox as response analyzed, with the intervention/control group as the main variable adjusting for potential confounders. Bivariate comparison using Student t test or Mann-Whitney test (continuous variables) and chi-square or Fisher's exact test (categorical variables). 165 subjects were required in the control group and 165 in the intervention group.

Conclusion: positive results of this study will bring out the brief information managed by family physicians increases the number of ADs thus facilitating the right to autonomy of the patient.

02

Conditions studied

  • Primary Care
  • Advance Directives
  • Randomized Controlled Trial

Keywords

  • primary care
  • advance directives
  • randomized controlled trial
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients older than 18 years old who go to their family doctor by appointment.

Exclusion criteria

Exclusion Criteria:

    • Patients with language barrier
  • Patients younger than 18 years (advanced directives not provided for by law)
  • Patients with altered decision-making ability according to computerized clinical history by coding in health problems or mentioned in a clinical course of computerized medical history : cognitive impairment, dementia, mental retardation diagnosed. Although there are studies on attitudes towards advanced directives of people with early cognitive impairment (Minimental> 18), it was decided to discard because the intervention should be brief. The cited study also concludes that this type of patients prefer to delegate decisions to the family.
  • Patients who come spontaneously to their family doctor.
  • Patients who have already been recruited previously in the study. Patients who may visit by appointment only on more than one occasion will only participate once and subsequent visits for recruitment will be excluded. In addition, there will be no reinforcement of the study intervention in these visits.
  • Patients who have already formalized the advanced directives.
  • Patients who do not wish to participate in the study.
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
330 participants (estimated)

Study arms

  • Experimental
    Brief information group

    Patients will be given brief information about the existence of advance directives after resolving the reason for the visit for which they had come. This information will not last more than 3 minutes and will not be repeated on successive visits within the recruitment period. Also, an informative triptych will be given to the patient so that he can read it at home. These leaflets have been made by the regional Department of Health. They will be advised that we can extend the information or help them to do the document in the near future if they want, we will inform that we would wait for the answer 3 months. In case of interest, they can leave their information in the User Service by specifying name, telephone number and reference doctor or ask for an appointment again.

    Other: Brief information group

  • No intervention
    Control group

    Patients who fall into a control group will only be attended to their reason for visiting and will be asked for the necessary data to obtain the independent variables if they do not appear in their history. If the patient in this group wants the information, he will be excluded from the study because he "refuses to participate."

Interventions

  • OtherBrief information group

    Patients will be given oral brief information about the existence of advance directives after resolving the reason for the visit for which they had come. This information will not last more than 3 minutes and will not be repeated on successive visits within the recruitment period. Also, an informative triptych will be given to the patient so that he can read it at home. These leaflets have been made by the regional Department of Health. They will be advised that we can extend the information or help them to do the document in the near future if they want, we will inform that we would wait for the answer 3 months. In case of interest, they can leave their information in the User Service by specifying name, telephone number and reference doctor or ask for an appointment again.

05

What researchers measure

Primary outcomes

  1. Interest in or performance of advance directives

    Proportion of people interested in or performance of Advance Directives in 3 months in the adult population. They will be obtained at the moment that the patient shows interest in the intervention of when they performance the Advance Directives, or if not, by asking by appointment or by telephone within 3 months of their recruitment

    Time frame: In 3 months

Secondary outcomes

  1. Baseline characteristics of those who perform or are interested in Advanced Directives

    Evaluate the baseline characteristics of those who perform or are interested in Advanced Directives (whether they are in the control or intervention group).

    Time frame: In 3 months

  2. Baseline characteristics of those performing Advanced directives in intervention group

    To assess the baseline characteristics of those performing the Advanced Directives and those not within the intervention group

    Time frame: In 3 months

  3. Reasons to performance Advanced directives

    Evaluate the reasons why patients finally formalize the document by open question (will be categorized if there is a limited number of responses, otherwise the reasons will be described qualitatively).

    Time frame: In 3 months

06

Study locations

1 of 1 sites recruiting
  • Institu Català de la Salut
    L'Hospitalet de Llobregat, Barcelona 08905, Spain
    Recruiting
07

References and documents

Study documents

  • Study protocol · Sep 14, 2017
  • Statistical analysis plan · Sep 14, 2017

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — For confidentiality

08

Registry details

Key details

Study ID
NCT03302572
Lead sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Responsible party
Sponsor
First posted
Oct 5, 2017
Start date
Nov 3, 2016
Primary completion
Mar 31, 2018 (estimated)
Completion
Mar 31, 2018 (estimated)
Last update
Oct 5, 2017

Study contacts

Yolanda Rando
Contact
yolanrando@gmail.com
+34616678030
Yolanda Rando
principal investigator · Institut Català de la Salut

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion